Scientific Research Analysis and Dissemination, American Association for Cancer Research, Philadelphia, Pennsylvania.
Cancer Epidemiol Biomarkers Prev. 2024 Jul 1;33(7):870-873. doi: 10.1158/1055-9965.EPI-24-0658.
Advances in cancer prevention, early detection, and treatments have led to unprecedented progress against cancer. However, these advances have not benefited everyone equally. Because of a long history of structural inequities and systemic injustices in the United States, many segments of the US population continue to shoulder a disproportionate burden of cancer. The American Association for Cancer Research (AACR) Cancer Disparities Progress Report 2024 (CancerDisparitiesProgressReport.org) outlines the recent progress against cancer disparities, the ongoing challenges faced by medically underserved populations, and emphasizes the vital need for further advances in cancer research and patient care to benefit all populations.
癌症防治、早期检测和治疗方面的进展使人类在对抗癌症方面取得了前所未有的进步。然而，这些进展并非惠及所有人。由于美国长期存在结构性不平等和制度性不公正，美国的许多人群仍然承受着不成比例的癌症负担。美国癌症研究协会（AACR）2024 年癌症差异进展报告（CancerDisparitiesProgressReport.org）概述了癌症差异方面的最新进展、医疗服务不足人群面临的持续挑战，并强调了癌症研究和患者护理方面进一步取得进展以造福所有人群的重要性。
